Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value ($000): $100,465 (100.0% shares, 0.0% debt)

Holdings (27)

SPARK THERAPEUTICS INC 8.3%
Value ($000) $8,309 Shares 162,500 Est. Cost $42.99 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 7.8%
Value ($000) $7,855 Shares 187,500 Est. Cost $55.90 Unrealized -11.7%
FOUNDATION MEDICINE INC 7.2%
Value ($000) $7,277 Shares 390,000 Est. Cost $19.10 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 7.1%
Value ($000) $7,134 Shares 430,000 Est. Cost $18.90 Unrealized
LOXO ONCOLOGY INC 6.9%
Value ($000) $6,954 Shares 300,000 Est. Cost $27.57 Unrealized
SAGE THERAPEUTICS INC 6.9%
Value ($000) $6,885 Shares 228,500 Est. Cost $48.15 Unrealized
BLUEPRINT MEDICINES CORP 6.9%
Value ($000) $6,885 Shares 340,000 Est. Cost $26.00 Unrealized
BLUEBIRD BIO INC 5.3%
Value ($000) $5,303 Shares 122,500 Est. Cost $60.25 Unrealized
EVH EVOLENT HEALTH INC 4.6%
Value ($000) $4,598 Shares 239,500 Est. Cost $13.73 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 4.0%
Value ($000) $4,023 Shares 72,500 Est. Cost $83.97 Unrealized -25.0%
KITE PHARMA INC 3.6%
Value ($000) $3,625 Shares 72,500 Est. Cost $52.20 Unrealized
GENMARK DIAGNOSTICS INC 3.6%
Value ($000) $3,611 Shares 415,000 Est. Cost $8.70 Unrealized
VYGR VOYAGER THERAPEUTICS INC 3.5%
Value ($000) $3,544 Shares 322,500 Est. Cost $17.92 Unrealized
EPIZYME INC 3.5%
Value ($000) $3,482 Shares 340,000 Est. Cost $14.50 Unrealized
CTMX CYTOMX THERAPEUTICS INC 2.4%
Value ($000) $2,392 Shares 234,179 Est. Cost $15.82 Unrealized -27.9%
MYOKARDIA INC 2.2%
Value ($000) $2,220 Shares 179,029 Est. Cost $14.07 Unrealized
CLOVIS ONCOLOGY INC 2.0%
Value ($000) $2,058 Shares 150,000 Est. Cost $13.72 Unrealized
IGNYTA INC 2.0%
Value ($000) $2,033 Shares 375,000 Est. Cost $5.82 Unrealized
SAGE THERAPEUTICS INC 1.9%
Value ($000) $1,958 Shares 65,000 Est. Cost $48.15 Unrealized
AVEXIS INC 1.7%
Value ($000) $1,711 Shares 45,000 Est. Cost $27.24 Unrealized
TESARO INC 1.7%
Value ($000) $1,681 Shares 20,000 Est. Cost $84.05 Unrealized
XBI SPDR SERIES TRUST 1.6%
Value ($000) $1,622 Shares 30,000 Est. Cost Unrealized
BMY BRISTOL MYERS SQUIBB CO 1.5%
Value ($000) $1,545 Shares 21,000 Est. Cost $46.69 Unrealized +8.1%
DXCM DEXCOM INC 1.2%
Value ($000) $1,190 Shares 15,000 Est. Cost $18.45 Unrealized -7.7%
DXCM DEXCOM INC 1.2%
Value ($000) $1,190 Shares 15,000 Est. Cost $18.45 Unrealized -7.7%
SYROS PHARMACEUTICALS INC 0.9%
Value ($000) $908 Shares 50,000 Est. Cost $18.16 Unrealized
MEDGENICS INC 0.5%
Value ($000) $472 Shares 85,000 Est. Cost $5.55 Unrealized